NB

Novel Bioventures

North America, Maryland, United States, Gaithersburg

Description

Novel Bioventures is a venture capital fund focused on early stage investments.

Investor Profile

Novel Bioventures has made 5 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series B (40%)
  • Series E (20%)
  • Series D (20%)
  • Series C (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Health Care
  • Medical
  • Medical Device
  • Service Industry
  • Wellness
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Novel Bioventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
Ascent Biomedical Ventures
North America, New York, United States, New York
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
MB
North America, New York, United States, New York
Co-Investments: 2
ATEL Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
Scottish Widows Investment Partnership
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
PV
Europe, England, United Kingdom, London
Co-Investments: 2
JL
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2

Which angels does Novel Bioventures often collaborate with?

GR
North America, Wisconsin, United States, Milwaukee
Shared Deals: 1

What are some of recent deals done by Novel Bioventures?

ARYx Therapeutics

Fremont, California, United States

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series EFeb 10, 2006
Amount Raised: $30,400,000
Cellerant Therapeutics

San Carlos, California, United States

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies.

BiotechnologyClinical TrialsTherapeutics
Series BMay 11, 2005
Amount Raised: $16,000,000
Predix Pharmaceuticals

Boston, Massachusetts, United States

Predix is a drug discovery and development company

Health CareMedicalPharmaceutical
Series CJan 27, 2005
Amount Raised: $43,000,000
ARYx Therapeutics

Fremont, California, United States

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series DJun 1, 2004
Amount Raised: $55,000,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series BJan 27, 2004
Amount Raised: $27,600,000